Centiva Capital’s Surgery Partners SGRY Stock Holding History

Centiva Capital’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84K	Sell	5,000 -206,299	-98%	-$2.9M	﹤0.01%	1547
2026 Q1	$2.52M	Buy	211,299 +60,743	+40%	+$872K	0.02%	380
2025 Q4	$2.33M	Buy	+150,556	New	+$2.77M	0.02%	412
2025 Q3	–	Sell	-90,000	Closed	-$2.01M	–	1762
2025 Q2	$2M	Buy	90,000 +40,000	+80%	+$889K	0.03%	349
2025 Q1	$1.19M	Sell	50,000 -52,150	-51%	-$1.23M	0.04%	388
2024 Q4	$2.16M	Buy	102,150 +64,550	+172%	+$1.69M	0.04%	294
2024 Q3	$1.21M	Buy	37,600 +21,290	+131%	+$629K	0.02%	735
2024 Q2	$388K	Buy	+16,310	New	+$418K	0.01%	1319
2024 Q1	–	Sell	-17,227	Closed	-$551K	–	2199
2023 Q4	$551K	Buy	+17,227	New	+$500K	0.01%	913
2023 Q3	–	Sell	-5,196	Closed	-$234K	–	2051
2023 Q2	$234K	Buy	+5,196	New	+$198K	0.01%	1253

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KSCM

King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Centiva Capital's SGRY Position: Q2 2026 in Review

Centiva Capital reduced its Surgery Partners (SGRY) stake by 98% in Q2 2026, selling an estimated $2.9M and leaving 5,000 shares worth $84K. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Centiva Capital first reported a position in SGRY in Q2 2023 and has held it in 10 quarters since. The position peaked at $2.52M in Q1 2026. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

Centiva Capital held 5,000 shares of Surgery Partners worth $84K as of Q2 2026.
Centiva Capital sold 206,299 Surgery Partners shares in Q2 2026, an estimated $2.9M.
Surgery Partners made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1547 holding.
Centiva Capital first reported a position in Surgery Partners in Q2 2023 and has held it in 10 quarters since.
Centiva Capital's Surgery Partners position peaked at $2.52M in Q1 2026.
187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.